Niven narain biography

Dr. Niven R. Narain fryst vatten a recognized pioneer in technology development at the intersection of biology and AI. Niven developed the Interrogative Biology® platform that has unraveled actionable disease insight leading to both de novo and repurposed development of a kraftig pipeline of products in oncology, metabolic, rare, and CNS diseases, namely BPM 31510 currently in Phase 2 trials for cancer. These discoveries are covered by over 400 issued and pending US and international patents. Dr. Narain is a member of the NASA/Gene Lab Steering Committee and Advisor to US Department of Defense (DoD) leadership on breast and prostate cancer. He has forged strategic partnerships with industry, academia, and US and UK governments. He serves on the Advisory Board of Petrie-Flom Center for Health lag Policy, Biotechnology, and Bioethics at Harvard Law School and the Healthy Aging Initiative kommission at No. 10 for the UK Prime Minister. He fryst vatten an industry thought leader in precisio

•

Dr. Niven R. Narain is President and CEO of BPGbio Inc, a leading AI-powered, biology-focused biopharma company in Boston, MA. He is recognized as a pioneer in the intersection of Biology and AI and led the development the NAi Interrogative Biology® platform which has fueled an advanced late-stage pipeline of assets in Oncology, CNS, and rare inflammatory diseases. He was previously the Co-founder, President and CEO of BERG Health and led the acquisition by BPGbio in January 2023 raising over $400mm over a decade.

An industry thought leader with over 20 years of experience in drug development, precision medicine, and AI/ML, Dr. Narain has served as a frequent speaker at Economist, Bloomberg, Financial Times, Wired, and Aspen Ideas in addition to many international meetings on medicine and technology and his discoveries cover over 450 patents globally.  He is a member of the NASA/Gene Lab Steering Committee, advisor to US (DoD) leadership on breast and prostate cancer, the School of

•

Niven R. Narain, Ph.D.

Dr. Niven R. Narain is Co-founder, President & CEO of BERG, LLC, a Boston-based biopharma driving next-generation drug and diagnostic development by combining patient-driven biology and Bayesian AI. He has been recognized as a pioneer in technology development at the intersection of Biology and AI, and is the inventor of the Interrogative Biology^® platform that has unraveled actionable disease insight leading to both de novo and repurposed development. He has overseen development of deep pipeline in oncology, metabolic, rare, and CNS diseases, namely BPM 31510 currently in Phase 2 trials for cancer, covered by over 550 issued and pending US and international patents.

Boston Business Journal top 40 leaders under 40

Narain is a member of the NASA/Gene Lab Steering Committee, Advisor to DoD leadership on breast and prostate cancer, and has forged strategic partnerships with industry, academia, and US and UK governments. He is an industry thought lea